Glodzik L, Galvin J, Pirraglia E, de Leon M.  2012.  Ordering of Alzheimer disease biomarkers.. Arch Neurol. 69(3):414;authorreply414-5.

Osorio RS, Pirraglia E, Agüera-Ortiz LF, During EH, Sacks H, Ayappa I, Walsleben J, Mooney A, Hussain A, Glodzik L et al..  2011.  Greater risk of Alzheimer's disease in older adults with insomnia.. J Am Geriatr Soc. 59(3):559-62.

Berti V, Mosconi L, Glodzik L, Li Y, Murray J, de Santi S, Pupi A, Tsui W, de Leon MJ.  2011.  Structural brain changes in normal individuals with a maternal history of Alzheimer's.. Neurobiol Aging. 32(12):2325.e17-26.

Mosconi L, Rinne JO, Tsui WH, Berti V, Li Y, Wang H, Murray J, Scheinin N, Någren K, Williams S et al..  2010.  Increased fibrillar amyloid-{beta} burden in normal individuals with a family history of late-onset Alzheimer's.. Proc Natl Acad Sci U S A. 107(13):5949-54.

Mosconi L, Glodzik L, Mistur R, McHugh P, Rich KE, Javier E, Williams S, Pirraglia E, de Santi S, Mehta PD et al..  2010.  Oxidative stress and amyloid-beta pathology in normal individuals with a maternal history of Alzheimer's.. Biol Psychiatry. 68(10):913-21.

Mosconi L, Berti V, Glodzik L, Pupi A, de Santi S, de Leon MJ.  2010.  Pre-clinical detection of Alzheimer's disease using FDG-PET, with or without amyloid imaging.. J Alzheimers Dis. 20(3):843-54.

Glodzik L, de Santi S, Rich KE, Brys M, Pirraglia E, Mistur R, Switalski R, Mosconi L, Sadowski M, Zetterberg H et al..  2009.  Effects of memantine on cerebrospinal fluid biomarkers of neurofibrillary pathology.. J Alzheimers Dis. 18(3):509-13.

Zhan J, Brys M, Glodzik L, Tsui W, Javier E, Wegiel J, Kuchna I, Pirraglia E, Li Y, Mosconi L et al..  2009.  An entorhinal cortex sulcal pattern is associated with Alzheimer's disease.. Hum Brain Mapp. 30(3):874-82.

Mosconi L, Mistur R, Switalski R, Tsui WHon, Glodzik L, Li Y, Pirraglia E, de Santi S, Reisberg B, Wisniewski T et al..  2009.  FDG-PET changes in brain glucose metabolism from normal cognition to pathologically verified Alzheimer's disease.. Eur J Nucl Med Mol Imaging. 36(5):811-22.

Brys M, Glodzik L, Mosconi L, Switalski R, de Santi S, Pirraglia E, Rich K, Kim BC, Mehta P, Zinkowski R et al..  2009.  Magnetic resonance imaging improves cerebrospinal fluid biomarkers in the early detection of Alzheimer's disease.. J Alzheimers Dis. 16(2):351-62.

Kamer AR, Craig RG, Pirraglia E, Dasanayake AP, Norman RG, Boylan RJ, Nehorayoff A, Glodzik L, Brys M, de Leon MJ.  2009.  TNF-alpha and antibodies to periodontal bacteria discriminate between Alzheimer's disease patients and normal subjects.. J Neuroimmunol. 216(1-2):92-7.

Glodzik L, King KG, Gonen O, Liu S, de Santi S, de Leon MJ.  2008.  Memantine decreases hippocampal glutamate levels: a magnetic resonance spectroscopy study.. Prog Neuropsychopharmacol Biol Psychiatry. 32(4):1005-12.

Mosconi L, Brys M, Switalski R, Mistur R, Glodzik L, Pirraglia E, Tsui W, de Santi S, de Leon MJ.  2007.  Maternal family history of Alzheimer's disease predisposes to reduced brain glucose metabolism.. Proc Natl Acad Sci U S A. 104(48):19067-72.